Clinical Genomics Technologies
clinicalgenomics.comLocations
Edison, NJ, USA · Bridgewater, NJ, USA · Sydney, NSW, Australia · Macquarie Park NSW 2113, Australia · Sydney NSW, Australia
industry
Biotechnology · Genetics · Health Care · Health Diagnostics · Oncology
Size
51 - 200 employees
Stage
Series B
founded in
2006
About
Clinical Genomics is a privately held biotechnology company developing innovative products for colorectal cancer diagnosis and monitoring. With a broad intellectual property portfolio including more than 20 issued and pending patents, Clinical Genomics has developed and validated a sensitive and specific blood test for colorectal cancer recurrence monitoring that will be launched in the U.S. in 2016. This 2-gene test, which is based on methylated DNA from two genes, BCAT1 and IKZF1, is currently known by its project name GEMINI.
Open jobs at Clinical Genomics Technologies
On-site & Remote
Job function
Seniority
Salary